Asian safinamide deal with Meiji Seika a partial salve for Newron
06 January 2012
Ian Haydock
Please Login to read the full article.
06 January 2012
Ian Haydock
ian.haydock@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Zambon exercises option on Merck reject safinamide as Newron shakes off the old
- Merck Serono safinamide boomerang 'completely unexpected' by Newron acquisitor BioTie
- CNS pipelines merged as Biotie buys Newron
- Newron steps up partnering for safinamide, aiming for deal before april 2012
FEATURES
- Interview: Adimab's Gerngross seeks two sweethearts
- Chinese producers may be losing price edge to India, says Granules MD
EVENTS
Today
Le Plaza Hotel, Brussels, Belgium
Today
Diplomat Hotel, Prague, Czech Republic
Today
Business Design Centre, London
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
